financetom
Business
financetom
/
Business
/
BRIEF-Johnson & Johnson Strengthens Pipeline to Lead in Atopic Dermatitis With the Completion of the Acquisition of Yellow Jersey Therapeutics, Gaining Ownership of NM26
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BRIEF-Johnson & Johnson Strengthens Pipeline to Lead in Atopic Dermatitis With the Completion of the Acquisition of Yellow Jersey Therapeutics, Gaining Ownership of NM26
Jul 11, 2024 5:29 AM

July 11 (Reuters) - Johnson & Johnson:

* JOHNSON & JOHNSON STRENGTHENS PIPELINE TO LEAD IN ATOPIC

DERMATITIS WITH THE COMPLETION OF THE ACQUISITION OF YELLOW

JERSEY THERAPEUTICS, GAINING OWNERSHIP OF NM26

Source text for Eikon:

Further company coverage:

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved